Luliford Lotion contains Luliconazole 1% w/v, a topical antifungal agent indicated for the treatment of various superficial fungal infections of the skin. Luliconazole belongs to the imidazole class of antifungals and exhibits broad-spectrum activity against dermatophytes, yeasts, and molds by inhibiting the synthesis of ergosterol, an essential component of fungal cell membranes. This disruption leads to increased membrane permeability and ultimately fungal cell death. Luliford Lotion is primarily prescribed for conditions such as tinea corporis, tinea cruris, and tinea pedis, providing effective relief from symptoms including itching, redness, scaling, and inflammation. The lotion formulation allows for easy application and rapid absorption, ensuring targeted delivery to the affected area. Typically, Luliford Lotion is applied once daily for a duration recommended by the healthcare provider, usually ranging from one to two weeks depending on the severity and type of infection. It is important to complete the full course of treatment to prevent recurrence. Luliford Lotion is generally well tolerated; however, mild local reactions such as burning, irritation, or erythema may occur. Patients should avoid contact with eyes and mucous membranes and discontinue use if hypersensitivity reactions develop. Consultation with a healthcare professional is advised before initiating therapy.